|Title:|| Dosage form for treating cardiovascular diseases|
|Abstract:||An osmotic device is disclosed comprising a first composition, and a second composition with the beneficial drug isradipine in the first composition.|
|Inventor(s):|| Ayer; Atul D. (Palo Alto, CA), Swanson; David R. (Palo Alto, CA), Kuczynski; Anthony L. (Palo Alto, CA) |
|Assignee:|| Alza Corporation (Palo Alto, CA) |
1. A composition for use in an osmotic device, said composition comprising about 2 weight percent to 30 weight percent of isradipine, a polyethylene oxide comprising a molecular weight
of about 200,000 to about 300,000 and a hydroxypropylemthylecellulose comprising a number average molecular weight of about 9,000 to 15,000.